Santen Pharmaceutical Asia Pte. Ltd. clinical trials

A country office of Santen Pharmaceutical Co., Ltd.

The registry lists 1 studies whose lead sponsor is Santen Pharmaceutical Asia Pte. Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 15, 2022.

Status

Status unknown: 1

Phase

Phase 4: 1

Where

Korea, Republic of: 1

Registry sponsor names on this page

Santen Pharmaceutical Asia Pte. Ltd.1 study

Something wrong with this grouping? Tell us on the Santen Pharmaceutical Co., Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Santen Pharmaceutical Co., Ltd. studies →

Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag IsopropylStatus unknownNCT05279716Phase 4
Sponsor listed in the registry: Santen Pharmaceutical Asia Pte. Ltd.